Crown Bioscience at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Crown Bioscience brings 7 presentations to ENA 2026 in Barcelona, and exhibits at Booth 30. Its posters cover patient-derived xenograft and organoid models for testing RAS inhibitors, protein degraders, antibody-drug conjugates and radiopharmaceuticals. It also reports that organoids grown from these xenografts closely match in vivo responses to KRAS inhibitors and ADCs, and presents mouse models for studying cancer cachexia.

Organization	ENA 2026 Attendance
Crown Bioscience San Diego, CA
crownbio.com CROs & CDMOsExhibitor Preclinical oncology CRO offering patient-derived xenograft, organoid and syngeneic models plus translational and biomarker services.	Booth Exhibiting at Booth 30 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Part of Poster session: Drug Resistance and Modifiers Developing Different Preclinical RAS Inhibitor Resistant Xenograft Models for Next-Generation Therapeutic Evaluation Targeted agents Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Part of Poster session: Molecular Targeted Agents Integrated Organoid Screening Approaches Enable Preclinical Assessment of Targeted Protein Degrader Efficacy and Target Engagement Targeted agents Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Animal Models Characterization of a Panel of PDX Models Derived from c-MET Targeting ADCs Pretreated Colorectal Cancer Patients for Therapeutic Evaluation Preclinical models Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Animal Models Establishing Preclinical Mouse Models for Translational Cancer Cachexia Research Preclinical models Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Preclinical Models End-to-end in vitro and in vivo evaluation of radiopharmaceuticals in patient-derived models Preclinical models Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Preclinical Models Benchmarking Multiple Comparison Procedures for Patient-Derived Xenograft Tumor-Volume Studies: Toward Statistically Justified and Ethically Grounded Study Design Preclinical models Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Preclinical Models PDX-Derived Organoids Demonstrate High Concordance with In Vivo Responses Across KRAS Inhibitors and Antibody-Drug Conjugates Preclinical models

Organization

ENA 2026 Attendance

Crown Bioscience

San Diego, CA

crownbio.com

CROs & CDMOsExhibitor

Preclinical oncology CRO offering patient-derived xenograft, organoid and syngeneic models plus translational and biomarker services.

Booth

Exhibiting at Booth 30

Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm

Poster

Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm